학술논문
The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer
Document Type
Article
Author
Source
In Radiotherapy and Oncology March 2024 192
Subject
Language
ISSN
0167-8140